Member Board of Directors @ (July 2023 - May 2025)
Entrepreneur in Residence @ (September 2021 - February 2025)
Immediate-Past President @ (March 2022 - May 2024)
President @ (May 2020 - March 2022)
President-Elect @ (June 2018 - May 2020)
Executive Vice President @ (April 2021 - July 2021)
Senior Vice President Discovery Biology @ (December 2020 - April 2021)
Executive Vice President Infectious Disease @ (April 2020 - November 2020)
Senior Vice President Infectious Disease @ (July 2018 - April 2020)
Head of Antiviral Research @ (February 2015 - July 2018)
Director Evaluation and Expertise @ (February 2013 - January 2015)
Scientific Director @ (December 2004 - February 2013)
Scientific Director @ (December 2004 - February 2013)
Senior Scientist @ Praecis Pharmaceuticals (January 2001 - January 2004)
Kara Carter Education
Harvard University
Post Doctoral Studies (Post Doctoral Studies)
1996-2001
University of Chicago
PhD (Virology)
1990-1996
Stanford University
BA (Human Biology)
1986-1990
Kara Carter Skills
Drug Discovery
Drug Development
Lifesciences
Immunology
Biotechnology
Biochemistry
Biopharmaceuticals
Assay Development
Cell Biology
Cell
Cell Culture
Clinical Development
Life Sciences
ELISA
Infectious Diseases
High Throughput Screening
Molecular Biology
Oncology
Protein Chemistry
Pharmaceutical Industry
Virology
Technology Transfer
Protein Purification
Strategic Planning
Microsoft Excel
Science
Kara Carter Summary
Kara Carter, based in Boston, MA, US, is currently a Chief Executive Officer at Stealth newco. Kara Carter brings experience from previous roles at Centauri Therapeutics Limited, Evotec and International Society for Antiviral Research (ISAR). Kara Carter holds a 1996 - 2001 Post Doctoral Studies in Post Doctoral Studies @ Harvard University. With a robust skill set that includes Drug Discovery, Drug Development, Lifesciences, Immunology, Biotechnology and more. Kara Carter has 2 emails and 3 mobile phone numbers on RocketReach.
Looking for a different Kara Carter?
Find contact details for 700 million professionals.